Please login to the form below

Not currently logged in
Email:
Password:

Glenmark

This page shows the latest Glenmark news and features for those working in and with pharma, biotech and healthcare.

Gilead and ViiV among winners at PM Society Digital Awards

Gilead and ViiV among winners at PM Society Digital Awards

Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well. .

Latest news

  • EMA suspends generic drugs on data integrity concerns EMA suspends generic drugs on data integrity concerns

    Included in the lengthy list of medicines affected by the suspension are products sold by Sandoz, Teva, Mylan, Sanofi, Biogaran Ratiopharm, Glenmark and Accord Healthcare, amongst many other firms, and most

  • Indian court blocks generic of Merck's Januvia Indian court blocks generic of Merck's Januvia

    India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

  • UCB files Vimpat patent claims against 15 companies UCB files Vimpat patent claims against 15 companies

    Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug. ... These other firms include major players in the generics market, such as Glenmark, Apotex, Mylan, Ranbaxy, Sandoz, Sun Pharma and

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    The patent infringement case against Glenmark centred on the salt form of sitagliptin used in Zita and Zita Met. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on the market.

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Glenmark Pharmaceuticals from selling a generic version of its Januvia and Janumet diabetes drugs. ... of its price in the US – while Glenmark's versions are sold at a 20-30 per cent discount.

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics